000 | 01992cam a2200397 4500500 | ||
---|---|---|---|
005 | 20250112051249.0 | ||
041 | _afre | ||
042 | _adc | ||
100 | 1 | 0 |
_aLutz, Gladys _eauthor |
700 | 1 | 0 |
_a Arguillère, Laurence _eauthor |
700 | 1 | 0 |
_a Barbaste, Caroline _eauthor |
700 | 1 | 0 |
_a Emin, Laurence _eauthor |
700 | 1 | 0 |
_a Fouilland, Patrick _eauthor |
700 | 1 | 0 |
_a Gaubert, Marine _eauthor |
700 | 1 | 0 |
_a Peltier, Anne _eauthor |
700 | 1 | 0 |
_a Rampillon, Barbara _eauthor |
700 | 1 | 0 |
_a Robert, Isabelle _eauthor |
700 | 1 | 0 |
_a Poupon, Florence _eauthor |
700 | 1 | 0 |
_a Page, Pascale _eauthor |
245 | 0 | 0 | _aDiscuss and Transform Work to Regulate the Addictive Behaviour of Professionals |
260 | _c2019. | ||
500 | _a90 | ||
520 | _aAddictive behaviour is an occupational health issue. In this context, we make two observations. Firstly, the consumption of psychotropic substances is both a contributory cause and symptom of occupational risks to be assessed. Secondly, prevention practices ignore this investigation and focus on a priori improvement of knowledge and behaviour. We defend the idea that the leaders must create the conditions to mobilise their experiential knowledge and those of the employees to understand and improve the interrelations between their work and their uses of medicines, alcohol or drugs. The aim is to organise or reinforce spaces for discussion about work that help to clarify the health strategies, the professional functions of the use psychotropic substances and their regulation in the workplace. | ||
690 | _aconsumption | ||
690 | _aprevention | ||
690 | _apsychotropic drugs | ||
690 | _awork environment | ||
690 | _awork | ||
690 | _aconsumption | ||
690 | _aprevention | ||
690 | _apsychotropic drugs | ||
690 | _awork environment | ||
690 | _awork | ||
786 | 0 | _nPsychotropes | 24 | 3 | 2019-04-08 | p. 57-82 | 1245-2092 | |
856 | 4 | 1 | _uhttps://shs.cairn.info/journal-psychotropes-2018-3-page-57?lang=en |
999 |
_c201723 _d201723 |